Russell HV - Search Results

1

Using decision modeling to guide drug allocation during a shortage.

Russell HV, Bernhardt MB, Berg S. Russell HV, et al. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26331. Epub 2016 Nov 15. Pediatr Blood Cancer. 2017. PMID: 27862980

2

Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.

Okcu MF, Wang RY, Bueso-Ramos C, Schober W, Weidner D, Andrassy R, Blakely M, Russell H, Ozkan A, Kuttesch J, Andreeff M, Chan KW, Ater J. Okcu MF, et al. Pediatr Blood Cancer. 2005 Nov;45(6):787-95. doi: 10.1002/pbc.20428. Pediatr Blood Cancer. 2005. PMID: 15929127

3

The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.

Russell HV, Golding LA, Suell MN, Nuchtern JG, Strother DR. Russell HV, et al. Pediatr Blood Cancer. 2005 Dec;45(7):916-9. doi: 10.1002/pbc.20520. Pediatr Blood Cancer. 2005. PMID: 16078212

4

Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy.

Russell H, Hicks MJ, Bertuch AA, Chintagumpala M. Russell H, et al. Pediatr Blood Cancer. 2009 Jul;53(1):23-7. doi: 10.1002/pbc.21981. Pediatr Blood Cancer. 2009. PMID: 19340853

5

Refractory dilated cardiomyopathy associated with metastatic neuroblastoma.

Carlson P, Jefferies JL, Kearney D, Russell H. Carlson P, et al. Pediatr Blood Cancer. 2010 Oct;55(4):736-8. doi: 10.1002/pbc.22569. Pediatr Blood Cancer. 2010. PMID: 20589652

6

Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report.

Berg SL, Cairo MS, Russell H, Ayello J, Ingle AM, Lau H, Chen N, Adamson PC, Blaney SM. Berg SL, et al. J Clin Oncol. 2011 Jan 20;29(3):316-23. doi: 10.1200/JCO.2010.30.8387. Epub 2010 Dec 13. J Clin Oncol. 2011. PMID: 21149673 Free PMC article. Clinical Trial.

7

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.

Russell HV, Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, Blaney SM, Villablanca JG. Russell HV, et al. Pediatr Blood Cancer. 2011 Aug;57(2):275-82. doi: 10.1002/pbc.22821. Epub 2010 Nov 12. Pediatr Blood Cancer. 2011. PMID: 21671363 Free PMC article. Clinical Trial.

8

Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.

Russell H, Swint JM, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu MF. Russell H, et al. Pediatr Blood Cancer. 2014 Jun;61(6):970-6. doi: 10.1002/pbc.24950. Epub 2014 Jan 22. Pediatr Blood Cancer. 2014. PMID: 24453105 Free PMC article.

9

Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implications.

Beaty RS, Bernhardt MB, Berger AH, Hesselgrave JE, Russell HV, Okcu MF. Beaty RS, et al. Among authors: russell hv. Pediatr Blood Cancer. 2015 Nov;62(11):1925-8. doi: 10.1002/pbc.25610. Epub 2015 Jul 7. Pediatr Blood Cancer. 2015. PMID: 26152314

10

Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?

Lin JL, Guillerman RP, Russell HV, Lupo PJ, Nicholls L, Okcu MF. Lin JL, et al. Among authors: russell hv. Pediatr Blood Cancer. 2016 Feb;63(2):202-5. doi: 10.1002/pbc.25750. Epub 2015 Sep 16. Pediatr Blood Cancer. 2016. PMID: 26376023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters